Clinical and laboratory aspects of Ro/SSA-52 autoantibodies

Autoimmunity Reviews

Volumn 10, Issue 3, 2011, Pages 150-154

  Defendenti, Caterina ^a   Atzeni, Fabiola ^b   Spina, Maria Francesca ^a   Grosso, Silvia ^a   Cereda, Aldo ^c   Guercilena, Giacinto ^d   Bollani, Simona ^a   Saibene, Simone ^a   Sarzi Puttini, Piercarlo ^b  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Melloni Hospital   (Italy)

^d Biological Sales Network   (Italy)

Author keywords

Anti Ro SSA52 autoantibodies; Autoimmune hepatitis; Cardiac rhythm disorders; Extractable nuclear antigens; Primary biliary cirrhosis; Sj gren's syndrome

Indexed keywords

RO ANTIBODY;

AUTOIMMUNE DISEASE; CELIAC DISEASE; CHRONIC LYMPHATIC LEUKEMIA; COMPLETE HEART BLOCK; HEART ARRHYTHMIA; HUMAN; LIVER DISEASE; LUNG CANCER; LUPUS ERYTHEMATOSUS; MYOSITIS; PROGENY; REVIEW; RHEUMATIC DISEASE; RISK FACTOR; SOLID TUMOR; SYSTEMIC SCLEROSIS;

ADULT; ANIMALS; ANTIBODY SPECIFICITY; ATRIOVENTRICULAR BLOCK; AUTOANTIBODIES; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYOSITIS; PREGNANCY; RIBONUCLEOPROTEINS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 78751610989     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.09.005     Document Type: Review

References (43)

1. Verstegen G., Duyck M.C., Meeus P., Ravelingien I., De Vlam K. Detection and identification of antinuclear antibodies (ANA) in a large community hospital. Acta Clin Belg 2009, 64:317-323.
2. Schulte-Pelkum J., Fritzler M., Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009, 8:632-637.
3. Anderson K., Beck J.S., Buchanan W.W., McElhinney A.J. Precipitating auto-antibodies in the connective tissue diseases. Ann Rheum Dis 1962, 21:360-369.
4. Clark G., Reichlin M., Tomasi T.B. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969, 102:117-122.
5. Alspaugh M.A., Tan E.M. Antibodies to cellular antigens in Sjogren's syndrome. J Clin Invest 1975, 55:1067-1073.
6. Mayer O. Anti-SSA/Ro and anti-SSB/La antibodies. What's new?. Ann.Med. Interne (Paris). 2002, 153:520-529.
7. Fukuda-Kamitani T., Kamitani T. Ubiquitination of Ro52 autoantigen. Biochem Biophys Res Commun 2002, 295:774-778.
8. Dorner T., Feist E., Schmidtke G., Micheel B., Hiepe F., Burmester G.R., Kloetzel P.M. Anti-52kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J Rheumatol 1996, 23:462-468.
9. Ceribelli A., Cavazzana I., Franceschini F., Quinzanini M., Rizzini F.L., Cattaneo R. Isotope switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2008, 26:117-120.
10. Hayashi N., Koshiba M., Nishimura K., Sugiyama D., Nakamura T., Morinobu S., Kawano S., Kumagai S. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008, 18:153-160.
11. Peene I., Meheus L., Keyser S., Humbel R., Veys E.M., De Keyser F. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 2002, 61:929-933.
12. Langguth D.M., Morris S., Clifford L., Wilson R.J., Neil J., Hogan P.G., Wong R.C. Specific testing for "isolated" anti-52kD SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value. J Clin Pathol 2007, 60:670-673.
13. Rutjes S.A., Jongen P., Van Den H.F., Pruijn G.J., van Venrooij W.J. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997, 109:32-40.
14. Rozman B., Bozic B., Kos-Golja M., Plesivcnik-Novljan M., Kveder T. Immunoserological aspects of idiopathic inflammatory muscle disease. Wien Klin Wochenschr 2000, 112:722-727.
15. Brouwer R., Hengstman G.J., Vree E.W., Ehrfeld H., Bozic B., Ghirardello A., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116-123.
16. Koenig M., Fritzler M.J., Targoff I.N., Troyanov Y., Senecal J.L. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007, 9:R78.
17. Granito A., Muratori P., Muratori L., Pappas G., Cassani F., Worthington J., et al. Antibodies to SS-A/Ro52kD and centromere in autoimmune liver disease; a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 2007, 26:831-838.
18. Defendenti C., Bollani S., Spina M.F., Croce A.M., Guercilena G., Saibeni S., et al. Local experience on frequency and significance of immunological overlap in the field of primary biliary cirrhosis (PBC). Microbiologia Medica 2008, 23:183-185.
19. Liaskos C., Bogdanos D.P., et al. Antibody responses specific for soluble liver antigen co-occur with Ro52 autoantibodies in patients with autoimmune hepatitis. Poster on SLA/Ro52 at EASL 2007 Barcelona. J Hepatology 2009, (suppl, 1):250.
20. Kumar V., Rajadhyaksha M., Wortman J. Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol 2001, 8:678-685.
21. Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol 2006, 22:674-679.
22. Toker E., Yavuz S., Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome. Br J Ophthalmol 2004, 88:384-387.
23. Cavazzana I., Franceschini F., Quinzanini M., Manera C., Del Papa N., Maglione W., et al. Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Clin Exp Rheumatol 2006, 24:59-64.
24. Franceschini F., Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity Rev 2005, 38:55-63.
25. Franceschini F., Cretti L., Quinzanini M., Rizzini F.L., Cattaneo R. Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA/Ro and to SSB/La. Lupus 1994, 3:419-422.
26. Catoggio L.J., Skinner R.P., Smith G., Maddison P.J. Systemic lupus erythematosus in the elderly. Clinical and serological characteristics. J Rheumatol 1984, 11:175-181.
27. Reichlin M., Harley J.B. Antibodies to Ro/SSA and the heterogeneity of systemic lupus erythematosus. J Rheumatol 1987, 14:112.
28. Fujimoto M., Shimozuma M., Yazawa N., Yazawa N., Kubo M., Ihn H., et al. Prevalence and clinical relevance of 52.kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis. Ann Rheum Dis 1997, 56:667-670.
29. Frank M.B., McCubbin V., Trieu E., Isenberg D.A., Targoff I.N. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 1999, 12:137-142.
30. Shusta E.V., Li J.Y., Boado R.J., Pardridge W.M. The Ro52/SS-A autoantigen has elevated expression at the brain microvasculature. NeuroReport 2003, 14:1861-1865.
31. Iniguez C., Mauri J., Medrano M., Larrodè P., Santos S., Pina J., Morales F. Sjögren's syndrome and multiple sclerosis. Neurologia 2001, 16:232-235.
32. Tzioufas A.G., Routsias J.G. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application. Autoimmunity Rev. 2010, 9:631-633.
33. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmunity Rev. 2010, 9:595-599.
34. Lu Q., Renaudineau Y., Cha S., Ilei G., Brooks W.E., Selmi C., Tzioufas A.G., et al. Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's Syndrome Symposium. Autoimmunity Rev. 2010, 9:627-630.
35. Jaeggi E., Laskin C., Hamilton R., Kingdom J., Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. A prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010, 55:2778-2784.
36. Chameides L., Truex R.C., Vetter V., Rashkind W.J., Galioto F.J., Noonan J.A. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977, 297:1204-1207.
37. Buyon J.P. Neonatal lupus syndromes. Systemic lupus erythematosus 2004, p449-p484. Elsevier Academic Press, San Diego, CA. Fourth edition. R. Lahita (Ed.).
38. Buyon J.P., Ben-Chetrit E., Karp S., Roubey R.A., Pompeo L., Reeves W.H., et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989, 84:627-634.
39. Brucato A., Frassi M., Franceschini F., Cimaz R., Faden D., Pisoni M.P., et al. A. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmuno-electrophoresis: a prospective study of 100 women. Arthritis Rheum 2001, 44:1832-1835.
40. Lazzerini P.E., Capecchi P.L., Hammoud M., Maffei S., Capecchi P.L., Selvi E., et al. Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: more than expected?. Autoimmunity Rev 2009, 9:40-44.
41. Nakken B., Jonsson R., Bolstad A.I. Polymorphisms of the Ro52 gene associated with anti-Ro 52 kD autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum 2001, 44:638-646.
42. Frank M.B., Itoh K., Fujisaku A., Pontarotti P., Mattei M.G., Neas B.R. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 1993, 52:183-191.
43. Zent C.S., Kay N.E. Autoimmune complications in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 2010, 23:47-59.